Sex Differences in Fear Conditioning: Mechanisms of Risk and Resilience for PTSD
恐惧调节的性别差异:创伤后应激障碍的风险和复原力机制
基本信息
- 批准号:8813484
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-01-01 至 2018-12-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAgeAreaBiological MarkersBlood specimenConditioned StimulusConflict (Psychology)DataDiagnosisDiscriminationEpidemiologyEstrogensEvaluationExtinction (Psychology)FemaleFrightFunctional disorderFundingGalvanic Skin ResponseGene ExpressionGenesGenetic PolymorphismGoalsGonadal Steroid HormonesGrantHigh PrevalenceHumanImageIn VitroIndividualLaboratoriesLaboratory StudyLearningMatched GroupMeasuresMolecularNaturePACAPR-1 proteinParticipantPeptidesPhasePlayPost-Traumatic Stress DisordersPremenopauseProcessPublishingRecoveryRecruitment ActivityReportingResearchResponse ElementsRiskRoleSafetySeveritiesSex CharacteristicsShockStimulusStressSymptomsTestingTrainingTraumaVariantVeteransVulnerable PopulationsWomanbiological adaptation to stresscohortcomputer generatedconditioned fearconditioningeffective therapyexperienceimprovedin vivolearning extinctionmalemenneuromechanismnovelpituitary adenylate cyclase activating polypeptideprogramsproliferative phase Menstrual cyclepublic health relevanceresilienceresponsesex
项目摘要
The goal of this project is to characterize sex differences in mechanisms of fear extinction learning and
retention that may account for differences in vulnerability for Posttraumatic Stress Disorder (PTSD) in
women versus men. A mechanism proposed to account for recovery from traumatic stress is variability in the
extinction of conditioned fear. While several studies have examined sex differences in fear conditioning and
extinction in healthy individuals, it is notable that few studies have systematically examined sex differences in
these measures in individuals with PTSD, which may represent a more vulnerable group. Our pilot data of
individuals with PTSD suggest that women have increased fear conditioning and decreased extinction learning
and recall, which may provide a mechanism that could explain the epidemiological findings. Another promising
discovery that may explain differential vulnerability in some women is related to the peptide, pituitary adenylate
cyclase-activating polypeptide (PACAP), which is a regulator of the stress response. Higher levels of PACAP
have been associated with greater fear conditioning and PTSD presence and severity in women, but not men.
Furthermore, estrogen modulates PACAP and has also been associated with enhanced extinction retention.
However, PACAP has not been studied for potential effects on extinction.
We propose to conduct a laboratory study of fear conditioning in male and female veterans with and without
PTSD to establish whether there are sex differences in fear extinction learning and retention in PTSD. This
study will also examine the role of PACAP in explaining PTSD group and sex differences in extinction ability.
We will recruit medically healthy trauma-exposed PTSD+ and PTSD- male and pre-menopausal female
veterans for participation in this study (n=108). Four age-matched groups (n=27 per group) will consist of: 1)
PTSD+ female veterans; 2) PTSD- female veterans; 3) PTSD+ male veterans; 4) PTSD- male veterans.
Participants will be trained in a 10-day fear conditioning task. On Day 1, they will be presented with computer-
generated neutral images that are paired (CS+) or unpaired (CS-) with a mild electrical shock (US) and skin
conductance responses will be assessed throughout. On Day 4, participants will undergo extinction training, in
which they will be shown the images but will not receive shock. Participants will return on Day 11 for an
evaluation of the durability of extinction. Blood samples will be drawn prior to each session to assess for levels
of PACAP and estrogen. We predict that PTSD participants will have decreased fear extinction learning and
retention compared to participants without PTSD. We also predict that men will have greater fear extinction
learning and retention compared to women. Women with PTSD will have decreased extinction learning and
retention compared to women without PTSD and men. We also predict that PACAP will be associated with
decreased extinction learning and retention in women, but not in men. Among women, PACAP levels will be
higher in PTSD+ participants compared to PTSD- participants. We will also explore whether lower PACAP
accompanied by higher estrogen will be associated with greater extinction learning and retention. The ultimate
goal of this research is to characterize sex differences in fear extinction processes in order to advance the
identification of the pathophysiology of PTSD that may vary by sex and may be influenced by PACAP and sex
hormones.
该项目的目标是描述恐惧消退学习和恐惧消除机制中的性别差异。
保留可能解释创伤后应激障碍(PTSD)脆弱性的差异
女性与男性。提出的一种解释创伤应激恢复的机制是
条件性恐惧的消失。虽然有几项研究探讨了恐惧调节和恐惧调节方面的性别差异
尽管在健康个体中存在灭绝现象,但值得注意的是,很少有研究系统地考察了健康个体中的性别差异。
这些措施针对患有创伤后应激障碍的个人,他们可能是一个更脆弱的群体。我们的试点数据
患有创伤后应激障碍 (PTSD) 的个体表明,女性的恐惧条件作用增强,消退学习能力减弱
和回忆,这可能提供一种解释流行病学发现的机制。另一个有希望的
可能解释某些女性的不同脆弱性的发现与垂体腺苷酸肽有关
环化酶激活多肽(PACAP),它是应激反应的调节剂。更高水平的 PACAP
女性的恐惧条件反射和创伤后应激障碍(PTSD)的存在和严重程度与男性的恐惧条件反射有关,但与男性无关。
此外,雌激素调节 PACAP,也与增强的消退保留有关。
然而,尚未研究 PACAP 对灭绝的潜在影响。
我们建议对男性和女性退伍军人进行一项实验室研究,了解有或没有
PTSD 以确定 PTSD 中恐惧消退学习和保留是否存在性别差异。这
研究还将检验 PACAP 在解释 PTSD 群体和消退能力中性别差异中的作用。
我们将招募身体健康、有创伤经历的 PTSD+ 和 PTSD- 男性和绝经前女性
参与这项研究的退伍军人 (n=108)。四个年龄匹配的组(每组 27 人)将包括: 1)
PTSD+ 女性退伍军人; 2)PTSD——女性退伍军人; 3) PTSD+男性退伍军人; 4) PTSD-男性退伍军人。
参与者将接受为期 10 天的恐惧调节任务的培训。第一天,他们将获得计算机
生成与轻度电击(US)和皮肤配对(CS+)或未配对(CS-)的中性图像
电导响应将在整个过程中进行评估。第 4 天,参与者将接受灭绝训练,
他们将看到图像但不会受到电击。参与者将于第 11 天返回参加
评估灭绝的持久性。每次治疗前都会抽取血样以评估其水平
PACAP 和雌激素。我们预测 PTSD 参与者的恐惧消退学习能力会下降,并且
与没有 PTSD 的参与者相比,保留率。我们还预测男性会对灭绝有更大的恐惧
与女性相比,学习和保留能力。患有创伤后应激障碍 (PTSD) 的女性的消退学习能力会下降,并且
与没有 PTSD 的女性和男性相比,保留率更高。我们还预测 PACAP 将与
女性的消退学习和保留能力下降,但男性则不然。在女性中,PACAP 水平将为
与 PTSD- 参与者相比,PTSD+ 参与者更高。我们还将探讨是否降低 PACAP
伴随着较高的雌激素将与更强的消退学习和保留相关。终极
这项研究的目标是描绘恐惧消退过程中的性别差异,以推进
识别 PTSD 的病理生理学,该病理生理学可能因性别而异,并可能受到 PACAP 和性别的影响
荷尔蒙。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SABRA INSLICHT其他文献
SABRA INSLICHT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SABRA INSLICHT', 18)}}的其他基金
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance inPosttraumatic Stress
Suvorexant:一种双重食欲素受体拮抗剂,用于治疗创伤后应激障碍的睡眠障碍
- 批准号:
10417029 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance inPosttraumatic Stress
Suvorexant:一种双重食欲素受体拮抗剂,用于治疗创伤后应激障碍的睡眠障碍
- 批准号:
10589068 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance inPosttraumatic Stress
Suvorexant:一种双重食欲素受体拮抗剂,用于治疗创伤后应激障碍的睡眠障碍
- 批准号:
9565433 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Sex Differences in Fear Conditioning: Mechanisms of Risk and Resilience for PTSD
恐惧调节的性别差异:创伤后应激障碍的风险和复原力机制
- 批准号:
10223177 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Sex Differences in Fear Conditioning: Mechanisms of Risk and Resilience for PTSD
恐惧调节的性别差异:创伤后应激障碍的风险和复原力机制
- 批准号:
10398029 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Sex Differences in Fear Conditioning: Mechanisms of Risk and Resilience for PTSD
恐惧调节的性别差异:创伤后应激障碍的风险和复原力机制
- 批准号:
9794748 - 财政年份:2014
- 资助金额:
-- - 项目类别:
相似国自然基金
HTRA1介导CTRP5调控脂代谢通路在年龄相关性黄斑变性中的致病机制研究
- 批准号:82301231
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PLAAT3降低介导线粒体降解异常在年龄相关性白内障发病中的作用及机制
- 批准号:82301190
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
跨尺度年龄自适应儿童头部模型构建与弥漫性轴索损伤行为及表征研究
- 批准号:52375281
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
ALKBH5通过SHP-1调控视网膜色素上皮细胞铁死亡在年龄相关性黄斑变性中的作用机制研究
- 批准号:82301213
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
视网膜色素上皮细胞中NAD+水解酶SARM1调控自噬溶酶体途径参与年龄相关性黄斑变性的机制研究
- 批准号:82301214
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Bayesian Statistical Learning for Robust and Generalizable Causal Inferences in Alzheimer Disease and Related Disorders Research
贝叶斯统计学习在阿尔茨海默病和相关疾病研究中进行稳健且可推广的因果推论
- 批准号:
10590913 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Microbiome-gut-brain dysfunction in prodromal and symptomatic Lewy body diseases
前驱期和症状性路易体病中的微生物组-肠-脑功能障碍
- 批准号:
10720677 - 财政年份:2023
- 资助金额:
-- - 项目类别:
A rigorous test of dual process model predictions for problematic alcohol involvement
对有问题的酒精参与的双过程模型预测的严格测试
- 批准号:
10679252 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Feasibility Trial of a Novel Integrated Mindfulness and Acupuncture Program to Improve Outcomes after Spine Surgery (I-MASS)
旨在改善脊柱手术后效果的新型综合正念和针灸计划的可行性试验(I-MASS)
- 批准号:
10649741 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Cafe Move: A Novel Program for Prevention of Age-Related Physical Frailty
Cafe Move:预防与年龄相关的身体虚弱的新计划
- 批准号:
10861960 - 财政年份:2023
- 资助金额:
-- - 项目类别: